SCHEMBL27259448

SCHEMBL27259448

C[C@@H](Oc1ccc(Oc2ccc3ccc(I)cc3n2)cc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
CYP2C19 P33261 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
HIF1A Q16665 1/20 0.42
GMNN O75496 1/20 0.42
LMNA P02545 1/20 0.42
APEX1 P27695 1/20 0.42
PMP22 Q01453 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3886045 0.86 AKR1C3 (0.47) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL27259406 0.86 TDP1 (0.48) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL13316457 0.86 TDP1 (0.48) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL3887994 0.85 CYP1A2 (0.43) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL3887207 0.85 CYP1A2 (0.57) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL1957784 0.85 CYSLTR2 (0.44) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL3890768 0.85 CYSLTR2 (0.44) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL29711483 0.85 CYSLTR2 (0.44) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL3885170 0.85 CYP1A2 (0.57) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL3573474 0.85 CYP1A2 (0.57) CYP1A2GAACYP2C9PKMCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024132001-A1 MULTITARGET NUCLEAR RECEPTOR LIGANDS BASED ON 2-(4-(QUINOLIN-2-YLOXY)PHENOXY)PROPANOIC ACID AND 2-(4-(QUINOXALIN-2-YLOXY)PHENOXY)PROPANOIC ACID FOR THE TREATMENT OF METABOLIC AND LIVER DISEASES CHARLES UNIVERSITY, FACULTY OF PHARMACY IN HRADEC KRALOVE (CZ) 2024-06-27 WO disclosed